Importantly, in prostate cancer, NEP expression is downregulated by extensive hypermethylation of the promoter region and reexpression of neprilysin by treating the animals with the demethylating agent 5-aza-2′-deoxycytidine was able to inhibit tumor formation in the prostates of athymic mice [139, 140]. This evidence concerns the gene MME and prostate cancer.